Skip to content

Member · Former member

Antonio DECARO

S&D · Italy · left on 1 February 2026

Group
S&D
Country
Italy
Roll-call participation
60.2 %ⓘ of 3 644 roll calls in office · chamber median 90.2 % · whole term, roll calls
With majority line
97.1 %ⓘ of 2 194 votes where the group had a line · S&D median 96.3 %
More facts (4)
National party
PD Partito Democratico
In office
16 Jul 2024 – 1 Feb 2026 (left on 1 February 2026)
Against clear line
51 of 2 163 votesⓘ
Member id
257122
More

Record

The member’s figures against the median of their group and of the chamber. Each vote counts the member in the group they belonged to that day.

Roll-call participation ⓘ

60.2 %

2 195 of 3 644 roll calls while in office

S&D median: 89.9 % (−29.6 pts)

Chamber median: 90.2 %

With majority line ⓘ

97.1 %

2 131 of 2 194 votes where their group had a line

S&D median: 96.3 % (+0.9 pts)

Against clear line ⓘ

2.4 %

51 of 2 163 votes where their group had a clear line

37 opposite (for ↔ against), 12 abstained against the line, 2 voted for or against when the line was to abstain

Abstention ⓘ

2.6 %

58 of 2 195 votes cast

Participation 60.2 % — S&D median 89.9 %, 138 members.ⓘ
Data as a table
Participation among the 138 members of the S&D with enough votes.
FigureParticipation
Antonio DECARO60.2 %
S&D median89.9 %
Lowest in the group30.4 %
Highest in the group99.6 %
Members138
With majority line 97.1 % — S&D median 96.3 %, 138 members.ⓘ
Data as a table
With majority line among the 138 members of the S&D with enough votes.
FigureWith majority line
Antonio DECARO97.1 %
S&D median96.3 %
Lowest in the group81.9 %
Highest in the group99.4 %
Members138
  • Whole term, 5 928 roll-call votes. The dots are the other members of S&D; no ranks.
  • “No vote recorded” is not the same as absent: leave, illness and chairing the sitting look the same.
  • A group’s line is inferred from its members’ votes — Parliament publishes no whip.

Votes, 3 644

Export

Every roll-call vote of the term with the member’s position, newest first.

Result: for–against–abstained. Majority line: how most of the member’s group voted that day (“Tie” when no position won). ≠ group marks a vote otherwise than a clear line (at least two thirds, with at least 10 members voting) of their group.
DateDecision and voteResultPositionMajority line
20 Jan 2026Just transition directive in the world of work: ensuring the creation of jobs and revitalising local economies Amendment 3 to recital F 187 for, 436 against, 24 abstainedPosition: No vote recorded Majority line: Against
20 Jan 2026Just transition directive in the world of work: ensuring the creation of jobs and revitalising local economies Amendment 2 to recital E 178 for, 454 against, 20 abstainedPosition: No vote recorded Majority line: Against
20 Jan 2026Just transition directive in the world of work: ensuring the creation of jobs and revitalising local economies Amendment 1 to recital A 288 for, 294 against, 63 abstainedPosition: No vote recorded Majority line: Against
20 Jan 2026Just transition directive in the world of work: ensuring the creation of jobs and revitalising local economies Amendment 13, adding text after paragraph 10 175 for, 455 against, 23 abstainedPosition: No vote recorded Majority line: Against
20 Jan 2026The 28th Regime: a new legal framework for innovative companies Final vote — text as a wholeAdopted 492 for, 144 against, 28 abstainedPosition: No vote recorded Majority line: For
20 Jan 2026The 28th Regime: a new legal framework for innovative companies Amendment 32, adding text after recital E 190 for, 450 against, 13 abstainedPosition: No vote recorded Majority line: Against
20 Jan 2026The 28th Regime: a new legal framework for innovative companies Amendment 31, adding text after recital C 193 for, 464 against, 3 abstainedPosition: No vote recorded Majority line: Against
20 Jan 2026The 28th Regime: a new legal framework for innovative companies Separate vote on citation 2 491 for, 139 against, 20 abstainedPosition: No vote recorded Majority line: For
20 Jan 2026The 28th Regime: a new legal framework for innovative companies Amendment 30 to citation 2 199 for, 445 against, 10 abstainedPosition: No vote recorded Majority line: Against
20 Jan 2026The 28th Regime: a new legal framework for innovative companies Amendment 27 to paragraph 41 162 for, 484 against, 18 abstainedPosition: No vote recorded Majority line: Against
20 Jan 2026The 28th Regime: a new legal framework for innovative companies Amendment 35 to paragraph 40 124 for, 500 against, 28 abstainedPosition: No vote recorded Majority line: Against
20 Jan 2026The 28th Regime: a new legal framework for innovative companies Amendment 26 to paragraph 40 136 for, 487 against, 24 abstainedPosition: No vote recorded Majority line: Against
20 Jan 2026The 28th Regime: a new legal framework for innovative companies Amendments 25 + 34 (voted as one) to paragraph 37 191 for, 423 against, 48 abstainedPosition: No vote recorded Majority line: Against
20 Jan 2026The 28th Regime: a new legal framework for innovative companies Amendment 21, adding text after paragraph 29 79 for, 561 against, 15 abstainedPosition: No vote recorded Majority line: Against
20 Jan 2026The 28th Regime: a new legal framework for innovative companies Amendment 14, adding text after paragraph 14 81 for, 518 against, 56 abstainedPosition: No vote recorded Majority line: Against
20 Jan 2026The 28th Regime: a new legal framework for innovative companies Amendment 11, adding text after paragraph 14 78 for, 528 against, 58 abstainedPosition: No vote recorded Majority line: Against
20 Jan 2026The 28th Regime: a new legal framework for innovative companies Amendment 29, adding text after paragraph 10 135 for, 471 against, 52 abstainedPosition: No vote recorded Majority line: Against
20 Jan 2026The 28th Regime: a new legal framework for innovative companies Amendment 7 to paragraph 10 — part 2 103 for, 500 against, 61 abstainedPosition: No vote recorded Majority line: Against
20 Jan 2026The 28th Regime: a new legal framework for innovative companies Amendment 28, adding text after paragraph 2 190 for, 454 against, 16 abstainedPosition: No vote recorded Majority line: Against
20 Jan 2026The 28th Regime: a new legal framework for innovative companies Amendment 33 to paragraph 2 196 for, 446 against, 15 abstainedPosition: No vote recorded Majority line: Against
20 Jan 2026The 28th Regime: a new legal framework for innovative companies Amendment 3, adding text after paragraph 1 116 for, 489 against, 56 abstainedPosition: No vote recorded Majority line: Against
20 Jan 2026Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest Final votePassed 503 for, 57 against, 108 abstainedPosition: No vote recorded Majority line: For
20 Jan 2026Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest Amendment 247, adding text after recital 22 224 for, 424 against, 20 abstainedPosition: No vote recorded Majority line: For
20 Jan 2026Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest Amendment 256, adding text after recital 12 362 for, 259 against, 34 abstainedPosition: No vote recorded Majority line: For
20 Jan 2026Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest Amendment 259 to recital 4 197 for, 454 against, 7 abstainedPosition: No vote recorded Majority line: Against
20 Jan 2026Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest Amendment 244, adding text after recital 3 227 for, 299 against, 138 abstainedPosition: No vote recorded Majority line: Abstained
20 Jan 2026Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest Amendment 187 to Article 23 527 for, 121 against, 15 abstainedPosition: No vote recorded Majority line: For
20 Jan 2026Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest Amendment 178 to Article 22 529 for, 120 against, 16 abstainedPosition: No vote recorded Majority line: For
20 Jan 2026Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest Amendment 170 to Article 21 525 for, 123 against, 14 abstainedPosition: No vote recorded Majority line: For
20 Jan 2026Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest Amendment 250 to Article 16, after paragraph 2 141 for, 516 against, 7 abstainedPosition: No vote recorded Majority line: Against
20 Jan 2026Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest Amendment 257 to Article 3, paragraph 1, point 5 325 for, 284 against, 33 abstainedPosition: No vote recorded Majority line: For
20 Jan 2026Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest Amendment 164 450 for, 205 against, 8 abstainedPosition: No vote recorded Majority line: For
20 Jan 2026Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest Amendment 163 528 for, 123 against, 10 abstainedPosition: No vote recorded Majority line: For
20 Jan 2026Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest Amendment 162 494 for, 152 against, 17 abstainedPosition: No vote recorded Majority line: For
20 Jan 2026Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest Amendment 159 517 for, 127 against, 15 abstainedPosition: No vote recorded Majority line: For
20 Jan 2026Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest Amendment 158 492 for, 159 against, 14 abstainedPosition: No vote recorded Majority line: For
20 Jan 2026Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest Proposal to reject the text 44 for, 600 against, 13 abstainedPosition: No vote recorded Majority line: Against
18 Dec 2025Continuous Belarusian hybrid attacks against Lithuania Final vote — text as a wholeAdopted 438 for, 37 against, 48 abstainedPosition: No vote recorded Majority line: For
18 Dec 2025Continuous Belarusian hybrid attacks against Lithuania Separate vote on recital H 455 for, 88 against, 11 abstainedPosition: No vote recorded Majority line: For
18 Dec 2025Continuous Belarusian hybrid attacks against Lithuania Paragraph 11 — part 2 431 for, 110 against, 11 abstainedPosition: No vote recorded Majority line: For
18 Dec 2025Continuous Belarusian hybrid attacks against Lithuania Paragraph 11 — part 1 472 for, 61 against, 24 abstainedPosition: No vote recorded Majority line: For
18 Dec 2025Continuous Belarusian hybrid attacks against Lithuania Amendment 2, adding text after paragraph 9 54 for, 483 against, 13 abstainedPosition: No vote recorded Majority line: Against
18 Dec 2025Continuous Belarusian hybrid attacks against Lithuania Amendment 1, adding text after paragraph 9 86 for, 463 against, 8 abstainedPosition: No vote recorded Majority line: Against
18 Dec 2025Continuous Belarusian hybrid attacks against Lithuania Separate vote on paragraph 9 429 for, 76 against, 51 abstainedPosition: No vote recorded Majority line: For
18 Dec 2025Continuous Belarusian hybrid attacks against Lithuania Paragraph 7 — part 2 441 for, 94 against, 23 abstainedPosition: No vote recorded Majority line: For
18 Dec 2025Continuous Belarusian hybrid attacks against Lithuania Paragraph 7 — part 1 451 for, 43 against, 65 abstainedPosition: No vote recorded Majority line: For
18 Dec 2025Continuous Belarusian hybrid attacks against Lithuania Amendment 3 to paragraph 4 385 for, 97 against, 78 abstainedPosition: No vote recorded Majority line: For
18 Dec 2025Decarbonisation and modernisation of EU fisheries, and the development and deployment of fishing gear Final vote — text as a wholeAdopted 450 for, 93 against, 37 abstainedPosition: No vote recorded Majority line: For
18 Dec 2025Decarbonisation and modernisation of EU fisheries, and the development and deployment of fishing gear Amendment 7, adding text after paragraph 77 219 for, 337 against, 24 abstainedPosition: No vote recorded Majority line: Against
18 Dec 2025Decarbonisation and modernisation of EU fisheries, and the development and deployment of fishing gear Amendment 6 to paragraph 61 204 for, 359 against, 13 abstainedPosition: No vote recorded Majority line: Against

Show all 50 votes on this page

Roll-call participation

One cell per sitting while in office, shaded by the share of that day’s roll calls the member voted in. The official attendance register is kept separately by Parliament.

No vote recorded on 27 of 76 sittings with roll calls.

"No vote recorded" is not the same as absent: leave, illness and chairing the sitting look the same.

Data as a table

Voting neighbours

Members who voted the same way most often in the roll calls they both took part in, within and outside the member’s group (group at the date of each vote), over all roll calls of the term.

At least 200 shared roll calls over at least six months in office together. Within = both sat in the same group on the date of the vote; a member who changed group can appear on both lists. Baseline = the median agreement of all pairs of members of the groups the two sat in on the date of each shared vote (within: the group they shared; outside: the two groups), weighted by the votes they shared in each combination.

Within S&D

Agreement: roll calls where both cast the same position, of the roll calls both voted in while in the same group (“shared”); a count below 50 shared. Baseline: the median agreement of every pair of members of that group.
SelectMemberGroupCountryAgreementBaseline
Matteo RICCI S&DItaly99 % of 1 862 shared93 %
Camilla LAURETI S&DItaly99 % of 2 184 shared93 %
Giuseppe LUPO S&DItaly98 % of 2 177 shared93 %
Alessandra MORETTI S&DItaly98 % of 1 914 shared93 %
Irene TINAGLI S&DItaly98 % of 2 125 shared93 %
Sandro RUOTOLO S&DItaly98 % of 1 958 shared93 %
Stefano BONACCINI S&DItaly98 % of 2 028 shared93 %
Annalisa CORRADO S&DItaly98 % of 2 012 shared93 %
Pierfrancesco MARAN S&DItaly98 % of 2 177 shared93 %
Giorgio GORI S&DItaly98 % of 1 913 shared93 %

Show all 10 neighbours

Outside the group

Agreement: roll calls where both cast the same position, of the roll calls both voted in while in different groups (“shared”); a count below 50 shared. Baseline: the median agreement of every pair of members of the groups the two sat in on those votes (groups at the date, weighted by the votes shared in each combination).
SelectMemberGroupCountryAgreementBaseline
Gerben-Jan GERBRANDY RenewNetherlands88 % of 2 129 shared86 %
Raquel GARCÍA HERMIDA-VAN DER WALLE RenewNetherlands88 % of 2 184 shared86 %
Charles GOERENS RenewLuxembourg88 % of 1 908 shared86 %
Valérie DEVAUX RenewFrance87 % of 1 739 shared86 %
Martin HOJSÍK RenewSlovakia87 % of 2 102 shared86 %
Lukas SIEPER changed group RenewGermany87 % of 2 051 shared33 %
Lucia YAR RenewSlovakia87 % of 2 146 shared86 %
Marjan ŠAREC RenewSlovenia87 % of 1 768 shared86 %
Jana TOOM RenewEstonia87 % of 2 089 shared86 %
Michal WIEZIK RenewSlovakia87 % of 2 143 shared86 %

Show all 10 neighbours

Work

Seats in committees, delegations and intergroups, and the dossiers the member leads, shadows or negotiates.

In the chamber

Speeches and statements in plenary debates, newest first; the verbatim report is on Parliament’s site.

21 contributions recorded; 3 on behalf of their group; 33 minutes of speaking time.

Show all 21 recent contributions

Questions and motions, 33

Parliamentary questions and motions for resolutions the member authored or co-signed, newest first.

Date: tabled. Title: the question or motion, with its id. Kind: written question or motion for a resolution, with the number of co-authors. Answer: the date of the answer to a question.
DateTitleKindAnswer
29 Jan 2026Activating EU funds and support instruments for Sicily, Sardinia and Calabria in the wake of Cyclone Harry P-10-2026-000378Priority written questionwith 20 co-authors12 Mar 2026
10 Dec 2025RECOMMENDATION FOR A DECISION to raise no objections to the Commission delegated regulation of 20 November 2025 supplementing Regulation (EU) 2023/956 of the European Parliament and of the Council by specifying the conditions for granting accreditation to verifiers, for the control and oversight of accredited verifiers, for the withdrawal of accreditation and for mutual recognition and peer evaluation of accreditation bodies B-10-2025-0565Motion for a resolution—
20 Nov 2025EU funding of companies linked to spyware and illegal surveillance E-10-2025-004636Written questionwith 54 co-authors20 Feb 2026
12 Nov 2025The sacking of journalist Gabriele Nunziati over a question he asked the Commission E-10-2025-004502Written questionwith 22 co-authorsNot yet answered
15 Oct 2025MOTION FOR A RESOLUTION on the EU strategic objectives for the 20th meeting of the Conference of the Parties to the Convention on International Trade in Endangered Species of Wild Fauna and Flora (CITES), to be held in Samarkand, Uzbekistan, from 24 November to 5 December 2025 B-10-2025-0450Motion for a resolutionwith 6 co-authors—
13 Oct 2025MOTION FOR A RESOLUTION on the UN Climate Change Conference 2025 in Belém, Brazil (COP30) B-10-2025-0445Motion for a resolutionwith 5 co-authors—
6 Oct 2025Defence of the European pasta sector against new US tariffs P-10-2025-003915Priority written questionwith 3 co-authors13 Nov 2025
25 Sept 2025Key objectives for the CITES COP20 meeting in Uzbekistan O-10-2025-000035Oral questionwith 5 co-authorsNot yet answered
25 Sept 2025Key objectives for the CITES COP20 meeting in Uzbekistan O-10-2025-000036Oral questionwith 5 co-authorsNot yet answered
11 Sept 2025UN Climate Change Conference 2025 in Belém, Brazil (COP30) O-10-2025-000029Oral questionwith 5 co-authorsNot yet answered

Show all 33 questions and motions

Amendments tabled in committee, 8

Committee amendment documents that carry amendments by the member, with how many are theirs.

Show all 8 amendment documents

Connections

Dossiers they lead or shadow, committees, party, delegation and other related pages.

Political group

National delegation

  • Delegation Italy National delegation

Sources & citation

Where the facts on this page come from, and how to cite it.

Data source
Licensed CC BY 4.0.
Data version
data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1 · methods
Retrieved
25 September 2026

Cite as

EU Parl Watch Research (2026). “Antonio DECARO”. Member record. memberId 257122. EU Parl Watch Research. https://news.eu-parl.st-solutions.dev/members/257122?page=5&vscope=all (retrieved 25 September 2026). Official source: Member’s profile, European Parliament, https://www.europarl.europa.eu/meps/en/257122. Data: EP Open Data: member record, https://data.europarl.europa.eu/api/v2/meps/257122?format=application%2Fld%2Bjson (CC BY 4.0); data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1.
BibTeX
@misc{epw-member-257122,
  author = {{EU Parl Watch Research}},
  title = {{Antonio DECARO}},
  year = {2026},
  howpublished = {\url{https://news.eu-parl.st-solutions.dev/members/257122?page=5&vscope=all}},
  url = {https://news.eu-parl.st-solutions.dev/members/257122?page=5&vscope=all},
  urldate = {2026-09-25},
  publisher = {EU Parl Watch Research},
  note = {Member record. memberId 257122. Official source: https://www.europarl.europa.eu/meps/en/257122. Data: EP Open Data: member record (CC BY 4.0); data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1}
}